Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1305
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01181271 | Tandem Auto-Allo Transplant for Lymphoma | ||
| NCT07064798 | Cryocompression for CIPN | ||
| NCT02135133 | A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL | ||
| NCT04624633 | Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL | ||
| NCT06565052 | The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial | ||
| NCT02285439 | Study of MEK162 for Children With Low-Grade Gliomas | ||
| NCT00879034 | A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria | ||
| NCT04627064 | ABEMA Alone or in COMBO With MK-6482 | ||
| NCT07227584 | ALL Backbone in AYAs | ||
| NCT02670525 | Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome | ||
| NCT01250717 | Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer | ||
| NCT01586182 | Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma | ||
| NCT06283251 | PediRISE Feasibility | ||
| NCT00378209 | Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma | ||
| NCT01177527 | Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders | ||
| NCT07052695 | Mosunetuzumab for CLL MRD Clearance | ||
| NCT03093272 | A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer | ||
| NCT00788775 | Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma | ||
| NCT01049230 | Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors | ||
| NCT03101254 | LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma | ||
| NCT06654466 | Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer | ||
| NCT02448537 | A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas | ||
| NCT00083031 | Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer | ||
| NCT00590902 | Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer | ||
| NCT05403801 | STAMP+CBT mHealth for Cancer Pain | ||
| NCT07439211 | Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia | ||
| NCT00630344 | RAD001 and Bicalutamide for Androgen Independent Prostate Cancer | ||
| NCT02971956 | Pembrolizumab in Refractory Advanced Esophageal Cancer | ||
| NCT00095875 | Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) | ||
| NCT00148707 | Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer | ||
| NCT07129265 | Understanding Vape Marketing Study | ||
| NCT00165334 | Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer | ||
| NCT00003966 | Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation | ||
| NCT05210101 | A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals | ||
| NCT00442130 | Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination | ||
| NCT04906200 | Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors | ||
| NCT00142129 | Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia | ||
| NCT02999477 | A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer | ||
| NCT00299767 | Phase I Study of Sequential Cord Blood Transplants | ||
| NCT05795101 | TRUDI: TDXD+Durva in HER2+/Low IBC | ||
| NCT01340300 | Exercise and Metformin in Colorectal and Breast Cancer Survivors | ||
| NCT00543114 | Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL | ||
| NCT01200238 | STA-9090(Ganetespib) in Metastatic Ocular Melanoma | ||
| NCT04620187 | Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas | ||
| NCT00139243 | Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck | ||
| NCT03122717 | Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer | ||
| NCT00632658 | Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease | ||
| NCT00601120 | RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma | ||
| NCT06677190 | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin | ||
| NCT02689401 | MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer |
